miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1
Metrics: PDF 654 views | HTML 983 views | ?
Chunhong Cao1,*, Deguang Sun1,*, Liang Zhang1, Lei Song1
1Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116027 Liaoning, China
*These authors have contributed equally to this work as the co-first author
Liang Zhang, email: firstname.lastname@example.org
Lei Song, email: email@example.com
Keywords: miR-186, Twist1, GC
Received: September 12, 2016 Accepted: October 17, 2016 Published: November 07, 2016
Recent evidence shows that miRNAs are dysregulated in a variety of cancers including gastric cancer (GC), and emerging as key oncogenes or tumor suppressors. In this study, qRT-PCR was used to analyze the expression of miR-186 in GC tissues and adjacent non-cancerous tissues, and then more in-vitro experiments were used to investigate the role of miR-186 in GC cells. Here, we identified miR-186 was generally down-regulated in GC tissues; however, Twist1 was generally up-regulated in GC tissues. Moreover, miR-186 and Twist1 were associated with larger tumor size and advanced clinical stage of GC. In-vitro experiments demonstrated that ectopic overexpression of miR-186 inhibited GC cell proliferation, invasion and migration; however, inhibited expression of miR-186 enhanced cell proliferation, invasion and migration. Furthermore, the luciferase reporter assay demonstrated Twist1 as a direct target of miR-186. Finally, over-expression of Twist1 abrogated inhibitory impact of miR-186 on cell proliferation, invasion and migration. In conclusion, miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1, and could be a tumor suppressor in GC development. Thus, miR-186 may be served as a candidate prognostic biomarker and target for new therapies in human gastric cancer.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.